Why the study?
Does hyperpolarized MR using [1-13C]pyruvate provide a method for the assessment of innate immune cell-driven inflammation in the heart after MI?
Does hyperpolarized MR using [1-13C]pyruvate provide a method for the assessment of innate immune cell-driven inflammation in the heart after MI?
Hyperpolarized MR with [1-13C]pyruvate represents a novel, noninvasive imaging modality for assessing cardiac inflammation post-MI with potential for clinical translation.
Answers are grounded in this paper and cite their sources.
May enable noninvasive imaging of post-MI inflammation in animals; leaves open human translation and clinical utility.
Hyperpolarized MR using [1-¹³C]pyruvate provides a novel method for the assessment of innate immune cell-driven inflammation in the heart after MI, with broad potential applicability across other cardiovascular disease states and suitability for early clinical translation.
No takes yet. Share an insight, caveat, or question.
Lewis et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: